0001127602-21-024770.txt : 20210902
0001127602-21-024770.hdr.sgml : 20210902
20210902162559
ACCESSION NUMBER: 0001127602-21-024770
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210902
DATE AS OF CHANGE: 20210902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galson Steven K
CENTRAL INDEX KEY: 0001495328
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 211233558
MAIL ADDRESS:
STREET 1: C/O BIOCRYST PHARMACEUTICALS, INC.
STREET 2: 4505 EMPEROR BLVD, SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-09-01
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001495328
Galson Steven K
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Non-Qualified Stock Option
16.15
2021-09-01
4
A
0
60000
0
A
2031-09-01
Common Stock
60000
60000
D
Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan.
The option vests 1/36 per month for a period of 36 months, beginning on October 1, 2021.
/s/ Jessica Dickerson, by power of attorney
2021-09-02